NAT14 anticorps (N-Term)

N° du produit ABIN2316725

Détail du produit anti-NAT14 anticorps

Antigène: NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))

Épitope: AA 12-41, N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NAT14 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Réactivité croisée: Humain, Souris

Réactivité croisée (Details): Calculated cross reactivity: Hu Mo

Attributs du produit: NAT14, NT (NAT14, KLP1, N-acetyltransferase 14, K562 cell-derived leucine-zipper-like protein 1)

Purification: Purified by Protein A affinity chromatography.

Immunogène: NAT14 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 12-41 amino acids from the N-terminal region of human NAT14.

Isotype: IgG

Information d'application

Indications d'application: Optimal working conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C

Détails sur NAT14

Antigène: NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))

Autre désignation: NAT14 (NAT14 Produits)

Synonymes: anticorps BC047219, anticorps KLP1, anticorps N-acetyltransferase 14, anticorps N-acetyltransferase 14 (putative), anticorps Nat14, anticorps NAT14

NCBI Accession: NP_065111

UniProt: Q8WUY8

Pathways: SARS-CoV-2 Protein Interactome